ARCHIVES

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

New Therapies Could Benefit Patients With Difficult Cancers

June 25, 2010

Komen, Baylr, UT Southwestern Form Alliance

November 13, 1987

Univ. Of Pittsburgh Seeks Senior Prevention Trial Of Tamoxifin should Resume

June 17, 1994

Breast Cancer Task Force Hears Update on Research, Abstract Excerpter

September 19, 1980

Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention

January 21, 2011

National Cancer Act Of 1971 Commemorated In Symposium Marking Progress, Future Goals

December 13, 1991